Log In
Print
BCIQ
Print
Print this Print this
 

QPI-1007

  Manage Alerts
Collapse Summary General Information
Company SBI Biotech Co. Ltd.
DescriptionShort interfering RNA (siRNA) that inhibits expression of caspase 2 (CASP2)
Molecular Target Caspase-2 (CASP2)
Mechanism of ActionGene silencing
Therapeutic ModalityNucleic acid: Linear RNA: siRNA
Latest Stage of DevelopmentPhase I
Standard IndicationOptic neuropathy
Indication DetailsTreat non-arteritic anterior ischemic optic neuropathy (NA-AION); Treat optic neuropathy (acute and severe optic nerve injury)
Regulatory Designation

Partner

Biocon Ltd.; BioSpring GmbH; Kunshan RiboQuark Pharmaceutical Technology Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today